Their results suggest that GDM has epigenetic effects on genes preferentially involved in the metabolic diseases pathway, with consequences on fetal growth and development, providing supportive evidence that DNA methylation is involved in fetal metabolic programming.
During cell wall assembly, biosynthesis of phenylpropanoid, protein, and carbohydrate constituents appeared to be inter-dependent, and the deficiency in a key-enzyme of the lignin pathway had consequences on the expression of several genes involved in cell wall metabolism.
In this review article, we will discuss how significant advances can be obtained by applying computational modeling approaches to elucidate the pathways most critically involved in tumor formation and progression, impact of particular mutations on pathway operation, consequences of altered cell behavior in tissue environments and effects of molecular therapeutics.
Firstly, the in-frame deletion inactivation of algC, i.e. a Δ algC strain, encoding wild-type MucA would allow us to observe potential roles of AlgC outside the alginate biosynthetic pathway, including consequences of potential effects on LPS [ 27] and rhamnolipid [ 28] biosynthesis.
However, more studies will be needed to understand the downstream cell signaling pathways, functional consequences, target genes, and suppression of HIF-1α to develop novel treatments or to inhibit tumor progression.
As a number of prominent cellular pathways are critical to the survival of both tumor cells and heart cells, it comes as little surprise that therapies targeting those pathways have consequences in both tissues.
In addition to the shared signaling pathways, temporal consequences are similar between in vivo and in vitro systems.
Whilst these data clearly highlight crosstalk between the HIF and NF-κB pathways, the consequences of these associations both in vitro and in vivo and the variation between the cell types studied makes functional interpretation of these existing data difficult.
As the biological pathways and consequences of ceramide metabolism continue to be elucidated for specific age‐associated diseases and treatments are developed, a more thorough understanding of the factors that affect ceramides in humans and how they change with age is needed.
We organize this presentation into five main categories, denoting the kinds of problems being addressed by the various studies: identifying dysregulated pathways, elucidating consequences of mutations on network activities, integrating network operation into cell behavioral functions, integrating cell behavior into tissue-level processes and predicting effects of molecular interventions.
